Bezlotoxumab - A New Agent for Clostridium difficile Infection
- PMID: 28121509
- DOI: 10.1056/NEJMe1614726
Bezlotoxumab - A New Agent for Clostridium difficile Infection
Comment on
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources